Surprisingly, in the subcutaneous tumor model, administration of a-TIGIT did not achieve better effects than injection of a-PD-1; we speculated that this was because only the bladder tumor microenvironment exhibited a higher expression of TIGIT. This evidence concerns the gene PDCD1 and neoplasm.